Department of Pharmacy
Department of Nursing
Critical Care
| Generic Name: | GCSF (Granulocyte Colony Stimulating Factor) |
| Trade Name: | Neupogen |
| Action: | Promotes Neutrophil Production |
| Indications: | Neutropenia Secondary to Immunosuppressive Drug Therapy |
| Administration Guidelines: | |
| Usual Dosage Range and Route: | 300 or 480 mcg subcutaneous or intravenous as titrated to patient response |
| Standard Concentration: (FOR IV ADMINISTRATION) | 15 mcg / ml or greater (i.e. 300 mcg / 20 ml over 30 - 60 minutes) |
| Special Considerations: | - Should not be used within 24 hours of
chemotherapy - Dose based on individual patient’s parameters - Subcutaneous administration is the preferred route |
| Precautions and Side Effects: | - Malaise - Arthralgia |
rev:9/00